Is Equillium Stock a Good Investment?

Equillium Investment Advice

  EQ
To provide specific investment advice or recommendations on Equillium stock, we recommend investors consider the following general factors when evaluating Equillium. This will help you to make an informed decision on whether to include Equillium in one of your diversified portfolios:
  • Examine Equillium's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Equillium's leadership team and their track record. Good management can help Equillium navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Equillium's business and its evolving consumer preferences.
  • Compare Equillium's performance and market position to its competitors. Analyze how Equillium is positioned in terms of product offerings, innovation, and market share.
  • Check if Equillium pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Equillium's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Equillium stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Equillium is a good investment.
 
Sell
 
Buy
Cautious Hold
We provide trade advice to complement the prevailing expert consensus on Equillium. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Equillium is not overpriced, please confirm all Equillium fundamentals, including its gross profit, short ratio, current liabilities, as well as the relationship between the total debt and market capitalization . Please also check Equillium number of shares shorted to verify your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Market Performance

Very WeakDetails

Volatility

Very riskyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

Very WeakDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Equillium Stock

Researching Equillium's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 36.0% of the company shares are held by company insiders. The book value of Equillium was currently reported as 0.6. The company recorded a loss per share of 0.35. Equillium had not issued any dividends in recent years.
To determine if Equillium is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Equillium's research are outlined below:
Equillium generated a negative expected return over the last 90 days
Equillium has high historical volatility and very poor performance
Equillium may become a speculative penny stock
The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M.
Equillium reports about 57.56 M in cash with (21.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.68, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Equillium has a very weak financial position based on the latest SEC disclosures
Roughly 36.0% of the company shares are held by company insiders
Latest headline from finance.yahoo.com: Markets EQ Unveils Strategic Purchase of Voice AI Trailblazer Helios Life Enterprises

Equillium Quarterly Cash And Short Term Investments

32.28 Million

Equillium uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Equillium. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Equillium's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Equillium's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Equillium's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-22
2024-03-31-0.09-0.07760.012413 
2021-03-24
2020-12-31-0.4-0.360.0410 
2019-05-13
2019-03-31-0.3-0.34-0.0413 
2020-03-26
2019-12-31-0.39-0.44-0.0512 
2019-11-12
2019-09-30-0.4-0.350.0512 
2023-11-08
2023-09-30-0.17-0.110.0635 
2023-08-09
2023-06-30-0.17-0.10.0741 
2022-05-12
2022-03-31-0.37-0.45-0.0821 

Know Equillium's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Equillium is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Equillium backward and forwards among themselves. Equillium's institutional investor refers to the entity that pools money to purchase Equillium's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Integrated Wealth Concepts Llc2023-12-31
40 K
Northern Trust Corp2023-12-31
35.2 K
Prudential Financial Inc2024-03-31
31.2 K
Capital Cs Group, Llc2023-12-31
19 K
Jane Street Group, Llc2023-12-31
12 K
Tower Research Capital Llc2023-12-31
9.4 K
Adar1 Capital Management Llc2023-12-31
6.5 K
Simplex Trading, Llc2024-03-31
5.2 K
Blackrock Inc2023-12-31
3.8 K
Decheng Capital Llc2023-12-31
4.4 M
Vanguard Group Inc2024-03-31
841.9 K
Note, although Equillium's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Equillium's market capitalization trends

The company currently falls under 'Micro-Cap' category with a market capitalization of 55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Equillium's market, we take the total number of its shares issued and multiply it by Equillium's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

23.85 Million

Equillium's profitablity analysis

Equillium's profitability indicators refer to fundamental financial ratios that showcase Equillium's ability to generate income relative to its revenue or operating costs. If, let's say, Equillium is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Equillium's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Equillium's profitability requires more research than a typical breakdown of Equillium's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.26)(0.28)
Return On Capital Employed(0.63)(0.66)
Return On Assets(0.26)(0.28)
Return On Equity(0.59)(0.62)
The company has Net Profit Margin (PM) of (0.32) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.26) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.26.
Determining Equillium's profitability involves analyzing its financial statements and using various financial metrics to determine if Equillium is a good buy. For example, gross profit margin measures Equillium's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Equillium's profitability and make more informed investment decisions.
The data published in Equillium's official financial statements usually reflect Equillium's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Equillium. For example, before you start analyzing numbers published by Equillium accountants, it's critical to develop an understanding of what Equillium's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Equillium's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Equillium's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Equillium's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Equillium. Please utilize our Beneish M Score to check the likelihood of Equillium's management manipulating its earnings.

Evaluate Equillium's management efficiency

Equillium has Return on Asset (ROA) of (0.1431) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1431. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.4817) %, which implies that it produced no returns to current stockholders. Equillium's management efficiency ratios could be used to measure how well Equillium manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/21/2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.66. At this time, Equillium's Total Current Liabilities is relatively stable compared to the past year. As of 05/21/2024, Liabilities And Stockholders Equity is likely to grow to about 67.5 M, while Non Current Liabilities Total is likely to drop slightly above 364.8 K.
Last ReportedProjected for Next Year
Book Value Per Share 0.65  0.62 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.65  0.62 
Enterprise Value Over EBITDA(0.19)(0.20)
Price Book Value Ratio 1.11  1.53 
Enterprise Value Multiple(0.19)(0.20)
Price Fair Value 1.11  1.53 
Enterprise Value2.7 M2.6 M
The analysis of Equillium's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Equillium's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Equillium Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.764

Basic technical analysis of Equillium Stock

As of the 21st of May, Equillium shows the Mean Deviation of 5.44, variance of 64.4, and Standard Deviation of 8.03. Equillium technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and collect data for thirteen technical drivers for Equillium, which can be compared to its peers. Please confirm Equillium risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Equillium is priced favorably, providing market reflects its regular price of 1.55 per share. Please also check Equillium jensen alpha, which is currently at (0.29) to verify the company can sustain itself at a future point.

Equillium's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Equillium insiders, such as employees or executives, is commonly permitted as long as it does not rely on Equillium's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Equillium insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Understand Equillium's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Equillium's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Equillium's intraday indicators

Equillium intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Equillium stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Equillium time-series forecasting models is one of many Equillium's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Equillium's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Equillium Stock media impact

Far too much social signal, news, headlines, and media speculation about Equillium that are available to investors today. That information is available publicly through Equillium media outlets and privately through word of mouth or via Equillium internal channels. However, regardless of the origin, that massive amount of Equillium data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Equillium news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Equillium relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Equillium's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Equillium alpha.

Equillium Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Equillium can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Equillium without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Equillium Corporate Management

Elected by the shareholders, the Equillium's board of directors comprises two types of representatives: Equillium inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Equillium. The board's role is to monitor Equillium's management team and ensure that shareholders' interests are well served. Equillium's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Equillium's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason KeyesChief OfficerProfile
Matthew RitterSenior DevelopmentProfile
Penny TomPrincipal OfficerProfile
Maple MDChief OfficerProfile
Krishna MDConsultantProfile

How to buy Equillium Stock?

To provide specific investment advice or recommendations on Equillium stock, we recommend investors consider the following general factors when evaluating Equillium. This will help you to make an informed decision on whether to include Equillium in one of your diversified portfolios:
  • Examine Equillium's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Equillium's leadership team and their track record. Good management can help Equillium navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Biotechnology space and any emerging trends that could impact Equillium's business and its evolving consumer preferences.
  • Compare Equillium's performance and market position to its competitors. Analyze how Equillium is positioned in terms of product offerings, innovation, and market share.
  • Check if Equillium pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Equillium's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Equillium stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Equillium is a good investment.

Already Invested in Equillium?

The danger of trading Equillium is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Equillium is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Equillium. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Equillium is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.35)
Revenue Per Share
1.085
Quarterly Revenue Growth
0.204
Return On Assets
(0.14)
Return On Equity
(0.48)
The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Equillium's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.